FindTrial
Sign In

Study for the screening of Auramine O stained tuberculosis mycobacteria and non-tuberculosis mycobacteria in paraffin samples by artificial intelligence

Study for the screening of Auramine O stained tuberculosis mycobacteria and non-tuberculosis mycobacteria in paraffin samples by artificial intelligence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019709
Enrollment
Unknown
Registered
2018-11-24
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis and NTM

Interventions

Gold Standard:The criteria for clinical TB diagnosis refer to ws288-2017, the health industry standard of the People's Republic of China
Index test:EasyScan&#32
TB6&#32
fluorescence&#32
image&#32
and&#32
scanning&#32
system
&#32
Auramine&#32
O&#32
stain
Anti-acid&#32
fast&#32

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The pathology showed granulomatous morphology and acid-fast staining of 500 cases

Exclusion criteria

Exclusion criteria: Tissue diameter less than 1mm is not included in the study because of too small tissue.

Design outcomes

Primary

MeasureTime frame
Auramine O;Artificial intelligence interprets Auramine O;—

Secondary

MeasureTime frame
acid-fast test;—

Countries

China

Contacts

Public ContactZhengwei Dong

Shanghai Pulmonary Hospital

wendydong@126.com+86 13681715879

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026